MAHLIFE.NS(MAHLIFE.NS)
MAHLIFE.NS
No analyst ratings available
No analyst price targets available for MAHLIFE.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $13.92B | $16.45B | $22.48B |
| Low | $11.77B | $13.10B | $18.41B |
| High | $17.61B | $21.05B | $28.60B |
| EBITDA Avg | $-2.72B | $-3.21B | $-4.39B |
| Low | $-3.44B | $-4.11B | $-5.59B |
| High | $-2.30B | $-2.56B | $-3.60B |
| EBIT Avg | $-3.19B | $-3.77B | $-5.15B |
| Low | $-4.04B | $-4.82B | $-6.56B |
| High | $-2.70B | $-3.00B | $-4.22B |
| Net Income Avg | $2.32B | $3.25B | $3.80B |
| Low | $1.01B | $2.54B | $2.90B |
| High | $3.22B | $4.26B | $5.14B |
| EPS Avg | $11.38 | $15.92 | $18.60 |
| Low | $4.94 | $12.44 | $14.23 |
| High | $15.78 | $20.86 | $25.19 |
| Analysts (Rev / EPS) | 7 / 6 | 7 / 6 | 5 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $2.21B | $3.83B | $4.27B |
| Low | $2.21B | $3.83B | $4.27B |
| High | $2.21B | $3.83B | $4.27B |
| EBITDA Avg | $-431M | $-748M | $-834M |
| Low | $-431M | $-748M | $-834M |
| High | $-431M | $-748M | $-834M |
| EBIT Avg | $-506M | $-878M | $-979M |
| Low | $-506M | $-878M | $-979M |
| High | $-506M | $-878M | $-979M |
| Net Income Avg | $715M | $940M | $1.00B |
| Low | $715M | $940M | $1.00B |
| High | $715M | $940M | $1.00B |
| EPS Avg | $3.50 | $4.60 | $4.90 |
| Low | $3.50 | $4.60 | $4.90 |
| High | $3.50 | $4.60 | $4.90 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |